Skip to content
EmergingResearch compoundReference only

F‑Phenibut

Fluorinated Phenibut, more potent, more lipophilic GABA-B agonist variant.

AnxiolyticSleep SupportGABA analogDepressantCalmGABA

Pharmacology

ClassGABA analog · Depressant · Calm
Primary targetGABA-B receptor agonist
Targets3 receptor targets
EvidenceReference only
Affected systemsGABA

Contents

Related comparisons

Phenibut vs F-Phenibut

WHAT IS F-PHENIBUT?

Detailed overview

Fluorophenibut is an unofficial analog produced by para-fluoro substitution on the phenyl ring of Phenibut. Increased lipophilicity yields faster blood-brain-barrier penetration and roughly 3-5× higher in vivo potency (correspondingly ~50-100 mg active dose instead of 200-400 mg), but proportionally higher tolerance and dependence risk. No clinical trials exist, only a safety profile extrapolated from Phenibut`s pharmacology. ⚠️ The withdrawal syndrome can be more severe than Phenibut withdrawal → ER-level treatment cases documented. Schedule II controlled in Alabama and Michigan (USA); banned in the UK under the Psychoactive Substances Act. Legal grey zone in other EU member states, sold as a "research chemical".

Mechanism

GABA-B agonist (Phenibut-like)

Half-life

No validated human data

Legal status

Not approved anywhere

Receptor profile

  • GABA-B receptorStrong
  • Alpha-2-delta calcium channelsModerate
  • GABA-A receptorWeak

Safety

Side effects, stop signs, contraindications

Side effects · 6

  • Sedation, drowsiness, impaired motor coordination
  • Rapidly developing tolerance, even after a few days of daily use
  • Physical dependence and severe withdrawal (anxiety, insomnia, tremor), potentially worse than phenibut
  • Rebound anxiety and irritability as the effect wears off
  • Hangover-like fatigue and cognitive dullness (brain fog)
  • Nausea, dizziness; at overdose respiratory depression and altered consciousness

Contraindications · 6

  • Pregnancy and breastfeeding
  • Combined with alcohol or other CNS depressants (benzodiazepines, opioids, gabapentinoids): life-threatening sedation and respiratory depression
  • History of substance use disorder or addiction (high dependence potential)
  • Abrupt discontinuation after prolonged use is contraindicated: gradual taper needed to avoid severe withdrawal
  • Driving and operating machinery should be avoided during the effect due to sedation
  • No validated human safety data, not an approved drug: long-term effects unknown, avoid without clinical supervision

Related Nootropics

Same therapeutic category

FAQ

FAQ

F-Phenibut is a chemically modified, fluorinated version of the well-known calming/anti-anxiety compound Phenibut, designed to work stronger and faster than the original. According to the description it crosses into the brain more easily and is noticeably more potent than Phenibut. No specific documented benefits or human trial results are given in the source, so this is essentially an experimental, poorly researched derivative.

Telegram

Have a question about F‑Phenibut?

Reach out to us on Telegram for a personalized stack. We'll be happy to help.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

Structure & chemistry

TypeAnxiolytic
FormulaC10H12FNO2
UpdatedJune 19, 2026
MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: June 19, 2026

The information here is strictly for educational and scientific purposes. It does not replace medical advice or clinical consultation, and it does not encourage illegal substance or pharmaceutical use. Data is sourced. When in doubt, consult your doctor.